GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Rosalind, a life sciences AI model built to speed biology, drug discovery, and translational medicine research workflows.

A newly designed AI-powered tool is effective in developing treatments to attack antibiotic-resistant bacteria by breaking ...

OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

BACKGROUND: Preeclampsia affects approximately 1 in 10 pregnancies, leading to severe complications and long-term health ...

A newly developed bioinformatics tool, MPGK, integrates Mendelian randomization, polygenic risk score, Gene Ontology, and the Kyoto Encyclopedia of Genes and Genomes pathway analyses into a unified ...

A trio of antimicrobial peptides that target multidrug-resistant bacteria has been identified from an unexpected (and amusing) source: camels. Researchers from Sultan Qaboos University (Muscat, Oman) ...

In an increasingly tech-driven world, specialization in bioinformatics will set graduate students in Tufts’ biology master’s program apart. Bioinformatics is a scientific subdiscipline situated at the ...

Factoring out nucleotide-level mutation biases from antibody language models dramatically improves prediction of functional mutation effects while reducing computational cost by orders of magnitude.

The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental. JITing, or “just-in-time” compilation, can make relatively slow ...